002094.SZ
Qingdao Kingking Applied Chemistry Co., Ltd. [002094.SZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002094.SZ Stock Summary
Top 10 Correlated ETFs
002094.SZ
Top 10 Correlated Stocks
002094.SZ
In the News
002094.SZ Financial details
Company Rating
Neutral
Market Cap
1.98B
Income
-845.77M
Revenue
2.84B
Book val./share
2.15
Cash/share
0.72
Dividend
-
Dividend %
-
Employees
2.81K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
-3.2
Forward P/E
-
PEG
-0.01
P/S
0.96
P/B
1.83
P/C
3.36
P/FCF
-2.82
Quick Ratio
0.65
Current Ratio
1.31
Debt / Equity
0.82
LT Debt / Equity
0.01
-
-
EPS (TTM)
-1.23
EPS next Y
-
EPS next Q
-
EPS this Y
4880.39%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-11.56%
Revenue Q/Q
6.99%
EPS Q/Q
3.16%
-
-
-
-
SMA20
-8.65%
SMA50
-23.48%
SMA100
-32.99%
Inst Own
-
Inst Trans
-
ROA
-26%
ROE
-58%
ROC
-0.55%
Gross Margin
7%
Oper. Margin
-30%
Profit Margin
-30%
Payout
-5%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.99-4.25
52W High
-39.5%
52W Low
+142%
RSI
34.65
Rel Volume
0.47
Avg Volume
22.08M
Volume
10.31M
Perf Week
-15.09%
Perf Month
-10.7%
Perf Quarter
-30.26%
Perf Half Y
-34.42%
-
-
-
-
Beta
0.361
-
-
Volatility
0.2%, 0.19%
Prev Close
-0.41%
Price
2.42
Change
-1.22%
002094.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 7.88 | 7.92 | 5.79 | 4.56 | 4.27 | |
| Net income per share | 0.15 | 0.07 | -0.83 | -0.03 | -1.27 | |
| Operating cash flow per share | -0.17 | 0.17 | -0.25 | -0.6 | 0.08 | |
| Free cash flow per share | -0.26 | 0.12 | -0.33 | -0.7 | 0.02 | |
| Cash per share | 1.79 | 2.52 | 2.14 | 1.78 | 1.6 | |
| Book value per share | 4.2 | 4.2 | 3.57 | 3.22 | 2.08 | |
| Tangible book value per share | 2.71 | 4.31 | 3.67 | 3.22 | 1.99 | |
| Share holders equity per share | 4.2 | 4.2 | 3.57 | 3.22 | 2.08 | |
| Interest debt per share | 2.54 | 1.83 | 1.46 | 1.4 | 1.42 | |
| Market cap | 3.37B | 3.32B | 2.58B | 3.12B | 2.97B | |
| Enterprise value | 3.81B | 2.83B | 2.09B | 2.82B | 2.8B | |
| P/E ratio | 32.3 | 68.42 | -4.53 | -177.58 | -3.39 | |
| Price to sales ratio | 0.62 | 0.61 | 0.65 | 0.99 | 1.01 | |
| POCF ratio | -28.39 | 28.76 | -14.68 | -7.59 | 57.13 | |
| PFCF ratio | -18.63 | 39.22 | -11.19 | -6.42 | 202.69 | |
| P/B Ratio | 1.16 | 1.14 | 1.05 | 1.4 | 2.07 | |
| PTB ratio | 1.16 | 1.14 | 1.05 | 1.4 | 2.07 | |
| EV to sales | 0.7 | 0.52 | 0.52 | 0.89 | 0.95 | |
| Enterprise value over EBITDA | 7.71 | 4.75 | -12.95 | 21.64 | -7.09 | |
| EV to operating cash flow | -32.05 | 24.51 | -11.89 | -6.84 | 53.86 | |
| EV to free cash flow | -21.03 | 33.43 | -9.06 | -5.79 | 191.07 | |
| Earnings yield | 0.03 | 0.01 | -0.22 | -0.01 | -0.29 | |
| Free cash flow yield | -0.05 | 0.03 | -0.09 | -0.16 | 0 | |
| Debt to equity | 0.58 | 0.41 | 0.38 | 0.41 | 0.65 | |
| Debt to assets | 0.28 | 0.21 | 0.2 | 0.2 | 0.29 | |
| Net debt to EBITDA | 0.88 | -0.82 | 3.04 | -2.35 | 0.43 | |
| Current ratio | 2.21 | 2.02 | 1.89 | 1.6 | 1.3 | |
| Interest coverage | 2.54 | 7.02 | -4.41 | 1.49 | -2.62 | |
| Income quality | -0.77 | 2.38 | 0.31 | 23.41 | -0.06 | |
| Dividend Yield | 0.04 | 0.02 | 0.02 | 0.02 | 0.01 | |
| Payout ratio | 1.23 | 1.7 | -0.11 | -4.11 | -0.05 | |
| Sales general and administrative to revenue | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.25 | 0.07 | 0.05 | 0.05 | 0.03 | |
| Capex to operating cash flow | 0.52 | -0.27 | 0.31 | 0.18 | -0.72 | |
| Capex to revenue | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | |
| Capex to depreciation | -1.64 | -0.82 | -1.61 | -1.38 | -0.64 | |
| Stock based compensation to revenue | 0 | 0 | 0.02 | 0.01 | 0 | |
| Graham number | 3.77 | 2.57 | 8.14 | 1.36 | 7.69 | |
| ROIC | 0.03 | 0.04 | -0.07 | 0.11 | -0.05 | |
| Return on tangible assets | 0.02 | 0.01 | -0.12 | 0 | -0.28 | |
| Graham Net | 0.29 | 1.46 | 0.97 | 0.55 | -0.07 | |
| Working capital | 1.98B | 2.11B | 1.67B | 1.25B | 521.54M | |
| Tangible asset value | 1.88B | 2.98B | 2.53B | 2.22B | 1.37B | |
| Net current asset value | 1.07B | 2.03B | 1.5B | 1.24B | 498.72M | |
| Invested capital | 0.58 | 0.41 | 0.38 | 0.41 | 0.65 | |
| Average receivables | 1.16B | 1.33B | 1.19B | 1.18B | 902.43M | |
| Average payables | 365.53M | 510.9M | 602.45M | 684.68M | 676.86M | |
| Average inventory | 843.87M | 938.03M | 876.55M | 722.42M | 532.59M | |
| Days sales outstanding | 92.8 | 84.77 | 100.32 | 147.01 | 66.15 | |
| Days payables outstanding | 33.05 | 50.85 | 55.27 | 108.2 | 73.37 | |
| Days of inventory on hand | 82.03 | 74.27 | 80.05 | 84.83 | 58.04 | |
| Receivables turnover | 3.93 | 4.31 | 3.64 | 2.48 | 5.52 | |
| Payables turnover | 11.04 | 7.18 | 6.6 | 3.37 | 4.98 | |
| Inventory turnover | 4.45 | 4.91 | 4.56 | 4.3 | 6.29 | |
| ROE | 0.04 | 0.02 | -0.23 | -0.01 | -0.61 | |
| Capex per share | -0.09 | -0.04 | -0.08 | -0.11 | -0.05 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.98 | 0.75 | 1.14 | 1.07 | 1.14 | |
| Net income per share | 0.01 | -1.29 | 0.03 | 0.02 | 0.02 | |
| Operating cash flow per share | 0.01 | -1.29 | 0.03 | -0.11 | 0 | |
| Free cash flow per share | 0.01 | -1.32 | 0.03 | -0.11 | 0 | |
| Cash per share | 0.73 | 1.6 | 0.76 | 0.64 | 0.72 | |
| Book value per share | 3.26 | 2.08 | 2.11 | 2.12 | 2.15 | |
| Tangible book value per share | 3.21 | 1.99 | 2.03 | 2.03 | 2.06 | |
| Share holders equity per share | 3.26 | 2.08 | 2.11 | 2.12 | 2.15 | |
| Interest debt per share | 1.43 | 1.37 | 1.7 | 1.75 | 1.77 | |
| Market cap | 2.36B | 2.97B | 2.72B | 2.52B | 2.69B | |
| Enterprise value | 2.84B | 2.8B | 3.35B | 3.27B | 3.4B | |
| P/E ratio | 112.57 | -0.84 | 33.56 | 57.65 | 59.54 | |
| Price to sales ratio | 3.47 | 5.73 | 3.44 | 3.41 | 3.4 | |
| POCF ratio | 450.27 | -3.34 | 134.25 | -34.5 | 2.6K | |
| PFCF ratio | 513.23 | -3.27 | 134.9 | -34.51 | -7.34K | |
| P/B Ratio | 1.04 | 2.07 | 1.86 | 1.72 | 1.81 | |
| PTB ratio | 1.04 | 2.07 | 1.86 | 1.72 | 1.81 | |
| EV to sales | 4.17 | 5.4 | 4.24 | 4.43 | 4.3 | |
| Enterprise value over EBITDA | 120.15 | -5.31 | 106.82 | 86.01 | 205.49 | |
| EV to operating cash flow | 541.74 | -3.15 | 165.47 | -44.77 | 3.29K | |
| EV to free cash flow | 617.49 | -3.08 | 166.28 | -44.8 | -9.29K | |
| Earnings yield | 0 | -0.3 | 0.01 | 0 | 0 | |
| Free cash flow yield | 0 | -0.31 | 0.01 | -0.03 | 0 | |
| Debt to equity | 0.43 | 0.65 | 0.79 | 0.81 | 0.82 | |
| Debt to assets | 0.21 | 0.29 | 0.35 | 0.37 | 0.37 | |
| Net debt to EBITDA | 20.29 | 0.32 | 20.16 | 19.74 | 43.09 | |
| Current ratio | 1.61 | 1.3 | 1.29 | 1.31 | 1.31 | |
| Interest coverage | 0.25 | -71.18 | 1.25 | 1.17 | 0.58 | |
| Income quality | 1 | 1 | 1 | -6.68 | 0.09 | |
| Dividend Yield | 0.01 | 0 | 0 | 0.01 | 0.01 | |
| Payout ratio | 3.07 | 0 | 0.52 | 1.64 | 1.26 | |
| Sales general and administrative to revenue | 0.13 | -0.08 | 0.03 | 0.01 | 0.07 | |
| Research and developement to revenue | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Capex to operating cash flow | -0.12 | 0.02 | 0 | 0 | -1.35 | |
| Capex to revenue | 0 | -0.04 | 0 | 0 | 0 | |
| Capex to depreciation | -0.04 | -1.22 | -0.01 | 0 | 0.07 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.74 | 7.75 | 1.18 | 0.87 | 0.89 | |
| ROIC | 0 | -0.37 | 0.01 | 0 | 0 | |
| Return on tangible assets | 0 | -0.28 | 0.01 | 0 | 0 | |
| Graham Net | -0.51 | -0.07 | -0.87 | -0.84 | -0.83 | |
| Working capital | 1.3B | 521.54M | 504.7M | 518.58M | 536.86M | |
| Tangible asset value | 2.23B | 1.37B | 1.4B | 1.41B | 1.42B | |
| Net current asset value | 1.28B | 498.72M | 485.99M | 499.96M | 521.64M | |
| Invested capital | 0.43 | 0.65 | 0.79 | 0.81 | 0.82 | |
| Average receivables | 1.13B | 833.56M | 547.92M | 586.97M | 626.07M | |
| Average payables | 678.53M | 579.88M | 433.45M | 326.26M | 353.91M | |
| Average inventory | 853.27M | 637.85M | 432.43M | 445.77M | 435.53M | |
| Days sales outstanding | 149.85 | 92.83 | 63.94 | 74.62 | 72.72 | |
| Days payables outstanding | 95.78 | 91.58 | 39.56 | 43.73 | 49.74 | |
| Days of inventory on hand | 131.41 | 72.45 | 53.17 | 60.7 | 54.42 | |
| Receivables turnover | 0.6 | 0.97 | 1.41 | 1.21 | 1.24 | |
| Payables turnover | 0.94 | 0.98 | 2.27 | 2.06 | 1.81 | |
| Inventory turnover | 0.68 | 1.24 | 1.69 | 1.48 | 1.65 | |
| ROE | 0 | -0.62 | 0.01 | 0.01 | 0.01 | |
| Capex per share | 0 | -0.03 | 0 | 0 | 0 |
002094.SZ Frequently Asked Questions
What is Qingdao Kingking Applied Chemistry Co., Ltd. stock symbol ?
Qingdao Kingking Applied Chemistry Co., Ltd. is a CN stock and trading under the symbol 002094.SZ
What is Qingdao Kingking Applied Chemistry Co., Ltd. stock quote today ?
Qingdao Kingking Applied Chemistry Co., Ltd. stock price is $2.42 today.
Is Qingdao Kingking Applied Chemistry Co., Ltd. stock public?
Yes, Qingdao Kingking Applied Chemistry Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 22.08M
- Market Capitalization 1.98B
- Employee 2.81K
- CEO Mr. Feng Jie Tang
- Headquarters Qingdao,CN
- IPO Date 2006-12-15
-
Website
https://www.chinakingking.com 
Qingdao Kingking Applied Chemistry Co., Ltd. produces and sells cosmetics, scented candles, and craft products in China and Internationally. The company provides skin care, make-up, fragrance, facial mask, maternal and infant products under the ALLL BEAUTY brand. It also sells through online channel. Qingdao Kingking Applied Chemistry Co., Ltd. was founded in 1993 and is based in Qingdao, China.
